Figure 1From: Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent mannerEx-vivo experimental schedule for Sitagliptin and Vildagliptin pre-treatment. (A) Sprague–Dawley rats were treated for 2 weeks Sitagliptin (100 mg/kg/day) or water. (B) Sprague–Dawley rats were treated for 2 weeks Vildagliptin (20 mg/kg/day) or water. All hearts were subjected to 35 minutes ischaemia followed by 120 minutes reperfusion (I/R).Back to article page